An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
‘I am so scared of them now’: Burned from overspending, some ‘buy now, pay later’ users warn others away
After racking up thousands of dollars in debt, som
In a first, surgeons successfully transplant a pig kidney into a man
A man got a kidney from in a pig in transplant ope
New Comments